Forte Biosciences

Forte Biosciences is a clinical-stage biopharmaceutical company focused on dermatology. Forte's lead product, FB-401, is a topical biologic therapy for the treatment of inflammatory skin conditions, developed in collaboration with the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (“NIAID”).